RUSNANOPRIZE International Nanotechnology Prize Award, Open Innovations Forum, Moscow, Russia, November 1st, 2013

 International Nanotechnology Award RUSNANOPRIZE 2013, at International Forum Open Innovations, Moscow, Russia,November 1st, 2013

Rus На русском Eng In English

The Prize is awarded to researchers, scientists and developers (up to three people) being the authors of scientific-technological discovery or discoveries in the field of nanotechnologies, and to the company being the first to apply the discovery (discoveries) to mass production with the annual turnover of at least $10 million and reached business success through the application of the discovery (discoveries).

 

RUSNANOPRIZE 2013 laureate prof. Robert S. Langer, David H. Koch Institute, MIT, USA

RUSNANOPRIZE 2013 laureate prof. Robert S. Langer, David H. Koch Institute, MIT, USA

The RUSNANOPRIZE International Nanotechnology Prize Committee awarded the winners of the 2013 prize, in the field of nanomaterials and surface modification. This year prize goes to Massachusetts Institute of Technology Institute Professor Robert Langer and Harvard Medical School Professor Omid Farokhzad for the development and industrialization of nanoparticle technologies for medical applications.

Prof. Langer and Prof. Farokhzad have created combined nanoparticles, the surfaces of which are covered with biological ligands, i.e. molecules that recognize specific targets in the body, for example, the surface of cancer cells. The interior of the nanoparticles is composed of biologically inert polymer which binds the active substance, for example docetaxel, which is traditionally used in chemotherapy. These particles may circulate for a long time and be retained in the blood, and so they accumulate only around the tumor cells. Based on this technology, in particular, drugs have been created for the treatment of brain tumors, which are difficult to treat with traditional methods.

Prof. Omid Farokhzad, M.D. Associate Professor Brigham and Women's Hospital Harvard Medical School

RUSNANOPRIZE 2013 laureate prof. Omid Farokhzad, M.D. Associate Professor Brigham and Women's Hospital Harvard Medical School

The winning research is a junction between biotechnology and material science. Prof. Langer’s research has laid foundation for new developments in the field of biomaterials as well as for applying nanomaterials in medicine and biology. Aside from his research in bio-compatible polymers for drug delivery systems with controlled release and synthetic polymers for tissue engineering, Prof. Langer has pioneered creating many other new types of biomaterials, like shape-memory polymers and materials with controlled surface properties.

RUSNANOPRIZE 2013 award was also given to US-based BIND Therapeutics Inc. for the successful commercial application of Prof. Langer’s and Prof. Farokhzad’s research, developing Accurins™ a new class of highly selective targeted and programmable therapeutics. 

RUSNANOPRIZE is established to promote Science and Business Integration, Public Awareness of the Achievements in the Nanotechnology Area, International Cooperation, Acknowledgement of the Role of Scientists and Manufacturers.

International RUSNANOPRIZE 2013 Award Committee is represented by famous scientists and innovation businessman, who are generally acknowledged to have achieved outstanding results in the field of this year Prize - nanomaterials and surface modification. This year prof. Yury Gogotsi, Director of the A. J. Drexel Nanotechnology Institute, distinguished chair and professor, Drexel University (USA), also was invited to International Prize Award Committee

Financial rewards, prize symbols and honorary diploma of the Prize are awarded to inventors, scientists and developers, the authors of the R&D projects or technologies implemented into production. The company that has achieved some significant commercial success due to the implementation of these technologies is awarded with an honorary diploma and a glass ball, which is a RUSNANOPRIZE symbol.

The RUSNANOPRIZE 2013 award ceremony was held on November 1 in Moscow as part of the Open Innovations Forum.

Open Innovations Forum, Moscow, Russia, November 1st, 2013

Open Innovations Forum, Moscow, Russia, November 1st, 2013

RUSNANO CEO Anatoly Chubais and Karlsruhe Institute of Nanotechnology professor Herbert Gleiter presented the annual international award in nanotechnology, RUSNANOPRIZE 2013

RUSNANO CEO Anatoly Chubais and Karlsruhe Institute of Nanotechnology professor Herbert Gleiter presented the annual international award in nanotechnology, RUSNANOPRIZE 2013

Member of international RUSNANOPRIZE 2013 Award Committee prof. Yury Gogotsi, Director of the A. J. Drexel Nanotechnology Institute, Drexel University, USA, and RUSNANOPRIZE 2013 laureate prof. Omid Farokhzad, M.D. Associate Professor Brigham and Women's Hospital Harvard Medical School

Member of international RUSNANOPRIZE 2013 Award Committee prof. Yury Gogotsi, Director of the A. J. Drexel Nanotechnology Institute, Drexel University, USA, and RUSNANOPRIZE 2013 laureate prof. Omid Farokhzad, M.D. Associate Professor Brigham and Women's Hospital Harvard Medical School

Member of international RUSNANOPRIZE 2013 Award Committee prof. Yury Gogotsi, Director of the A. J. Drexel Nanotechnology Institute, Drexel University, USA, visited International Open Innovations Forum

Member of international RUSNANOPRIZE 2013 Award Committee prof. Yury Gogotsi, Director of the A. J. Drexel Nanotechnology Institute, Drexel University, USA, visited International Open Innovations Forum

Source: www.rusnanoprize.ru

 

 

News from MRC.ORG.UA

RIC2D MX-Innovation project on MXene production for water desalination and medical diagnostics takes off — Ukraine-based MXene manufacturing company Carbon-Ukraine (Y-Carbon LLC) on board!

MXene Carbon-Ukraine company in MX-Innovation project RIC2D with Dreexl University and Khakifa University

Carbon-Ukraine team is very exited to particpate in newly launched "MX-Innovation" three-year multinational collaboration project led by Prof. Yury Gogotsi, Drexel University (USA) to produce MXene nanomaterials. The project, which is a collaboration with Drexel University USA, Kalifa University in the UAE, the University of Padua in Italy and the Kyiv, Ukraine-based MXene manufacturing company Carbon-Ukraine, seeks to use MXene for water desalination and medical diagnostics. 

 
Joint patent application MRC, Carbon-Ukraine and Drexel University on highly porous MAX phase precursor for MXene synthesis published!

altExellent news, our joint patent application with Drexel University on highly porous MAX phase precursor for MXene synthesis published. Congratulations and thanks to all team involved!

 
Join us at the IEEE NAP-2025 International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future", Bratislava, September 7-12, 2025

MXene Symposium 2025 in BratislavaLast Call! Have you submitted your abstract for IEEE NAP-2025 yet? Join us at the International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene-focused conference in Europe this year!  Final Submission Deadline: May 15, 2025. Don’t miss this exclusive opportunity to showcase your research and engage with world leaders in the MXene field!

 
New Publication Alert: "MXenes in Healthcare: Transformative Applications and Challenges in Medical Diagnostics and Therapeutics"

MXene in healthcareWe are excited to announce the publication of latest review article on MXenes in Healthcare. This comprehensive review explores the groundbreaking role of MXenes—an emerging class of 2D materials—in revolutionizing the fields of medical diagnostics and therapeutics.  Read the full article here: https://doi.org/10.1039/D4NR04853A.

 
Pulsed Electrochemical Exfoliation for an HF-Free Sustainable MXene Synthesis

Electrochemical etching of Ti 3 AlC 2 pellet electrodes in aqueous electrolytes: Set-up and workflow with schematic mechanisms to generatedelaminated EC-MXene flakesCongratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved.

 
Elucidation of Potential Genotoxicity of MXenes Using a DNA Comet Assay

Potential Genotoxicity of MXenes Using a DNA Comet Assay. ACS Appl. Bio Mater. 2024, 7, 12, 8351-8366Congratulations to all collaborators with this interesting joint work!

 MXenes are among the most diverse and prominent 2D materials. They are being explored in almost every field of science and technology, including biomedicine. Despite their proven biocompatibility and low cytotoxicity, their genotoxicity has not been addressed, so we investigated whether MXenes interfere with DNA integrity in cultured cells and examined the fragmentation of their chromosomal DNA by a DNA comet assay. 

 
Ti₃C₂Tₓ MXene–silk fibroin composite films: engineering DC conductivity and properties in the THz range

MXene-silk composite film studyThank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about  MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties

 
2024 MRS Fall Meeting & Exhibit, Boston, Massachusetts, from December 1-6, 2024

2024 MRS Fall Meeting & Exhibit, Poster Session, from left to right: Prof. Yury Gogotsi, Prof. Maksym Pogorielov, Prof. Goknur Buke, Dr. Babak Anasori and Dr. Oleksiy GogotsiDr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.

 
Electrochemical real-time sensor for the detection of Pb(II) ions based on Ti3C2Tx MXene

Action of MXene-modified electrode in sensor application

We are proud to present our collaborative paper on an electrochemical real-time sensor for the selective detection of Pb(II) ions, powered by Ti₃C₂Tₓ MXene. Big thank you to our collaborators from Vilnius for extensive experiments and to make it published! This work lays the foundation for further development of in situ electrochemical sensors based on MXenes and their potential integration into lab-on-a-chip systems, enabling fast, portable, and cost-effective measurements for a wide range of applications.

 
Our team participated in the 3rd International Conference at Drexel University "MXene: Changing the World", August 5-7, 2024

3rd international MXene Confernce at Drexel University, August 5-7, 2024, Philadelphia, USAMRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field. 

 
Visit to our project partners from Worcester Polytechnic Institute that joined to ESCULAPE research project consortium

Visiting Functional Biomaterials Lab at Worcester Polytechnic Institute led by Dr. Jeannine Coburne

Looking forward to work together with Dr. Lyubov Titova and Dr. Jeannine Coubourne from Worcester Polytechnic Institute on structural and biomedical applications of MXenes and study of their properties within HORIZON EUROPE MSCA RISE ESCULAPE project!

 
MXenes for biomedical applications: MXene-Polydopamine-antiCEACAM1 Antibody Complex as a Strategy for Targeted Ablation of Melanoma

MXene-Polydopamine-antiCEACAM1 Antibody Complex fro cancer therapyTogether with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.

 
Looking forward our collaboration with Dr. Vladimir Tsukruk's team from Georgia Tech University in trilateral research project IMPRESS-U on MXene-Based Composite Bio-membranes with Tailored Properties

SSU, MRC and Carbon-Ukraine team visited research group led by Prof. Vladimir Tsukruk from Georgia Tech University, Atlanta, USA

Looking forward our collaboration with Dr. Vladimir Tsukruk's team from Georgia Tech University in trilateral research project IMPRESS-U, involving teams from Ukraine, Latvia, and the United States funded by National Science Foundation (NSF). project is focused on MXene-Based Composite Bio-membranes with Tailored Properties. Can't wait our Kick-off meeting that will be held at Latvias University in Riga with all project participants.

 

 
Our new collaborative research paper with Drexel team on Porous Ti3AlC2 MAX phase enables efficient synthesis of Ti3C2Tx MXene

porous MAX phase technologyIn this study, we have optimized the synthesis of MAX phases for MXene manufacturing. The main purpose of this study is to develop a porous Ti3AlC2MAX phase that can be easily ground into individual grains manually without time-consuming eliminating the need for drilling and intenseball-milling before MXene synthesis. Moreover, we also demonstrate the synthesis of highly porous Ti3AlC2 (about 70%) from an inexpensive raw materials.

 
Novel electrically conductive electrospun PCL‑MXene scaffolds for cardiac tissue regeneration

Scanning electron microscopy image of PCLMXene membranes crosssection (left side) with the representation of EDX line (dotted line) and example of cross-sectional EDX elements line scan (right side)Here we demonstrate a new developed method for depositing Ti3C2Tx MXenes onto hydrophobic electrospun PCL membranes using oxygen plasma treatment. These novel patches hold tremendous potential for providing mechanical support to damaged heart tissue and enabling electrical signal transmission,thereby mimicking the crucial electroconductivity required for normal cardiac function. After a detailed investigation of scaffold-to-cell interplay, including electrical stimulation, novel technology has the potential for clinical application not only for cardiac regeneration, but also as neural and muscular tissue substitutes.